20.500.12556/DiRROS-8155
Epitelijski rak jajčnikov, rak jajcevodov, primarni peritonealni serozni karcinom (PPSC) : priporočila za sistemsko zdravljenje
Epithelial ovarian cancer, fallopian tube cancer, primary peritoneal serous cancer (PPSC) : systemic treatment recommendations
Epithelial ovarian cancer is known to be one of the most sensitive to systemic treatment with chemotherapy. Objective response to treatment was achieved in more than 80% of patients. Therefore, chemotherapy treatment is a standard part of primary treatment after completed surgery (adjuvant treatment), If surgical treatment is not possible, patients begin treatment with preoperative (neoadjuvant) chemotherapy, which is followed by surgery. In primary systemic treatment, we have been using chemotherapy in combination with taxanes and platinum-based preparations. In systemic treatment of fallopian tube cancer, we also use – besides chemotherapy – bevacizumab, an inhibitor of the vascular endothelial growth factor (VEGF). Systemic treatment presents the principal treatment also in disease recurrence. The type of systemic treatment in disease recurrence depends on the time elapsed since the end of primary treatment until recurrence. In the last couple of years, we have been again witnessing the introduction of new medicines for treatment of patients with fallopian tube cancer. For this reason, the Institute of Oncology Ljubljana this year updated its guidelines for systemic treatment of epithelial ovarian cancer. In this paper, we present the current recommendations for systemic treatment of epithelial ovarian cancer in Slovenia. Epithelial ovarian cancer, fallopian tube cancer and primary peritoneal serous cancer (PPSC) have the same clinical course and the same systemic treatment, therefore they are all managed in the same manner.
rak (medicina)
jajčniki
kemoterapija
zdravljenje
smernice
true
false
true
Slovenski jezik
Angleški jezik
by Authors
Neznano
2018-01-03 12:27:29
2018-03-19 11:26:02
2022-08-16 09:56:57
0000-00-00 00:00:00
2015
0
0
str. 17-21, 37
št. 1
Letn. 19
jun. 2015
0000-00-00
Zaloznikova
Objavljeno
NiDoloceno
0000-00-00
0000-00-00
0000-00-00
618.11-006-08
1408-1741
2139259
65324032
RAZ_Skof_Erik_i2015.pdf
RAZ_Skof_Erik_i2015.pdf
1
CF7C26D6ABA97E73F260289C1F9753A1
f91f1560b8174b680783cd941f98b523729aa9cdbe1011f16c22d06d0f6388c2
481731f5-17b5-11ed-b6b8-001a4af901a5
20.500.12556/dirros/946923f3-d6b6-46b3-88f4-2f2c9109db0a
https://dirros.openscience.si/Dokument.php?lang=slv&id=10106
Onkološki inštitut Ljubljana
Onkologija : strokovni časopis za zdravnike
0
0
0